|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
| We’re going down soon, to move to a new Data Center today. We’ll be up ASAP. Sorry. |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/30/22 ENDRA Life Sciences Inc. 10-K 12/31/21 65:5M Blueprint/FA |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 899K
2: EX-4.12 Description of Securities HTML 36K
3: EX-21.1 Subsidiaries of the Company HTML 17K
4: EX-23.1 Consent of Expert or Counsel HTML 17K
5: EX-23.2 Consent of Expert or Counsel HTML 16K
6: EX-31.1 Certification -- §302 - SOA'02 HTML 20K
7: EX-31.2 Certification -- §302 - SOA'02 HTML 21K
8: EX-32.1 Certification -- §906 - SOA'02 HTML 18K
14: R1 Cover HTML 90K
15: R2 Condensed Consolidated Balance Sheets HTML 115K
16: R3 Condensed Balance Sheets (Parenthetical) HTML 38K
17: R4 Condensed Statements of Operations HTML 80K
18: R5 Condensed Consolidated Statements of Stockholders HTML 81K
Equity (Unaudited)
19: R6 Condensed Statements of Cash Flows HTML 108K
20: R7 Nature of the Business HTML 21K
21: R8 Summary of Significant Accounting Policies HTML 52K
22: R9 Inventory HTML 20K
23: R10 Fixed Assets HTML 27K
24: R11 Accounts Payable and Accrued Liabilities HTML 28K
25: R12 Bank Loans HTML 22K
26: R13 Capital Stock HTML 33K
27: R14 Common Stock Options and Restricted Stock Units HTML 42K
(RSU's)
28: R15 Common Stock Warrants HTML 34K
29: R16 Commitments and Contingencies HTML 38K
30: R17 Income Taxes HTML 76K
31: R18 Subsequent Events HTML 24K
32: R19 Summary of Significant Accounting Policies HTML 85K
(Policies)
33: R20 Summary of Significant Accounting Policies HTML 26K
(Tables)
34: R21 Fixed Assets (Tables) HTML 26K
35: R22 Accounts Payable and Accrued Liabilities (Tables) HTML 28K
36: R23 Common Stock Options and Restricted Stock Units HTML 42K
(RSU's) (Tables)
37: R24 Common Stock Warrants (Tables) HTML 32K
38: R25 Commitments and Contingencies (Tables) HTML 26K
39: R26 Income Taxes (Tables) HTML 77K
40: R27 Summary of Significant Accounting Policies HTML 24K
(Details)
41: R28 Summary of Significant Accounting Policies HTML 43K
(Details Narrative)
42: R29 Inventory (Details Narrative) HTML 20K
43: R30 Fixed Assets (Details) HTML 28K
44: R31 Fixed Assets (Details Narrative) HTML 20K
45: R32 Accounts Payable and Accrued Liabilities (Details) HTML 33K
46: R33 Bank Loans (Details Narrative) HTML 30K
47: R34 Capital Stock (Details Narrative) HTML 94K
48: R35 Common Stock Options and Restricted Stock Units HTML 51K
(RSUs) (Details)
49: R36 Common Stock Options and Restricted Stock Units HTML 41K
(RSUs) (Details 1)
50: R37 Common Stock Options and Restricted Stock Units HTML 44K
(RSUs) (Details Narrative)
51: R38 Common Stock Warrants (Details 1) HTML 54K
52: R39 Common Stock Warrants (Details Narrative) HTML 51K
53: R40 Commitments and Contingencies (Details) HTML 36K
54: R41 Commitments and Contingencies (Details Narrative) HTML 61K
55: R42 Income Taxes (Details) HTML 26K
56: R43 Income Taxes (Details 1) HTML 46K
57: R44 Income Taxes (Details 2) HTML 59K
58: R45 Income Taxes (Details 3) HTML 38K
59: R46 Income Taxes (Details Narrative) HTML 31K
60: R47 Subsequent Events (Details Narrative) HTML 30K
63: XML IDEA XML File -- Filing Summary XML 109K
61: XML XBRL Instance -- ndra_10k_htm XML 875K
62: EXCEL IDEA Workbook of Financial Reports XLSX 72K
11: EX-101.CAL XBRL Calculations -- ndra-20211231_cal XML 109K
13: EX-101.DEF XBRL Definitions -- ndra-20211231_def XML 369K
10: EX-101.LAB XBRL Labels -- ndra-20211231_lab XML 832K
12: EX-101.PRE XBRL Presentations -- ndra-20211231_pre XML 643K
9: EX-101.SCH XBRL Schema -- ndra-20211231 XSD 158K
64: JSON XBRL Instance as JSON Data -- MetaLinks 283± 378K
65: ZIP XBRL Zipped Folder -- 0001654954-22-004172-xbrl Zip 264K
EXHIBIT 21.1
Subsidiaries of the Registrant
ENDRA Life Sciences Canada Inc. is a corporation formed under the laws of Ontario, Canada in July 2017 and is wholly owned by the Company.
ENDRA Life Sciences Holding B.V. was organized under the laws of The Netherlands on July 27, 2020 and is wholly owned by the Company.
ENDRA Life Sciences Ltd. was organized under the laws of the United Kingdom on August 5, 2020 and is wholly owned by ENDRA Life Sciences Holding B.V.
ENDRA Life Sciences B.V. was organized under the laws of The Netherlands on August 11, 2020 and is wholly owned by ENDRA Life Sciences Holding B.V.
ENDRA Life Sciences GmbH was organized under the laws of Germany on September 9, 2020 and is wholly owned by ENDRA Life Sciences Holding B.V.
ENDRA Life Sciences S.A.R.L. was organized under the laws of France on January 26, 2021 and is wholly owned by ENDRA Life Sciences Holding B.V.
| This ‘10-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 3/30/22 | 4, 424B5, 8-K, S-8 | ||
| For Period end: | 12/31/21 | |||
| 1/26/21 | ||||
| 9/9/20 | ||||
| 8/11/20 | ||||
| 8/5/20 | ||||
| 7/27/20 | ||||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 5/10/24 ENDRA Life Sciences Inc. S-1/A 9:1.1M Blueprint/FA 4/19/24 ENDRA Life Sciences Inc. S-1 9:1.1M Blueprint/FA 3/28/24 ENDRA Life Sciences Inc. 10-K 12/31/23 67:4.8M Blueprint/FA 4/19/23 ENDRA Life Sciences Inc. S-1/A 1:357K Blueprint/FA 4/18/23 ENDRA Life Sciences Inc. S-1/A 5:515K Blueprint/FA 3/30/23 ENDRA Life Sciences Inc. S-1 6:959K Blueprint/FA 3/16/23 ENDRA Life Sciences Inc. 10-K 12/31/22 60:4.2M Blueprint/FA |